BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009;13:9-22. [DOI: 10.1016/j.smrv.2008.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Bjartmar L, Alkhori L, Ruud J, Mohammed AH, Marcusson J, Hallbeck M. Long-term treatment with antidepressants, but not environmental stimulation, induces expression of NP2 mRNA in hippocampus and medial habenula. Brain Research 2010;1328:25-33. [DOI: 10.1016/j.brainres.2010.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Chokroverty S, Avidan AY. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2012. pp. 1634-702. [DOI: 10.1016/b978-1-4377-0434-1.00093-1] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
4 España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep 2011;34:845-58. [PMID: 21731134 DOI: 10.5665/SLEEP.1112] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
5 Haq IZ, Naidu Y, Reddy P, Chaudhuri KR. Narcolepsy in Parkinson's disease. Expert Rev Neurother 2010;10:879-84. [PMID: 20518604 DOI: 10.1586/ern.10.56] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
6 Lindström M, Schinkelshoek M, Tienari PJ, Kukkonen JP, Renkonen R, Fronczek R, Lammers GJ, Itkonen O. Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS/MS and immunoassays. Clin Biochem 2021;90:34-9. [PMID: 33539807 DOI: 10.1016/j.clinbiochem.2021.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Alóe F, Alves RC, Araújo JF, Azevedo A, Bacelar A, Bezerra M, Bittencourt LR, Bustamante G, Cardoso TA, Eckeli AL, Fernandes RM, Goulart L, Pradella-Hallinan M, Hasan R, Sander HH, Pinto LR Jr, Lopes MC, Minhoto GR, Moraes W, Moreira GA, Pachito D, Pedrazolli M, Poyares D, Prado L, Rizzo G, Rodrigues RN, Roitman I, Silva AB, Tavares SM. [Brazilian guidelines for the diagnosis of narcolepsy]. Braz J Psychiatry 2010;32:294-304. [PMID: 20585744 DOI: 10.1590/s1516-44462010005000014] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Lim MM, Szymusiak R. Neurobiology of Arousal and Sleep: Updates and Insights Into Neurological Disorders. Curr Sleep Medicine Rep 2015;1:91-100. [DOI: 10.1007/s40675-015-0013-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
9 Jagadish S, Singer W, Kotagal S. Autonomic dysfunction in childhood hypersomnia disorders. Sleep Med 2021;78:43-8. [PMID: 33385777 DOI: 10.1016/j.sleep.2020.11.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Bridoux A, Moutereau S, Covali-Noroc A, Margarit L, Palfi S, Nguyen JP, Lefaucheur JP, Césaro P, d'Ortho MP, Drouot X. Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease. Nat Sci Sleep 2013;5:87-91. [PMID: 23847436 DOI: 10.2147/NSS.S41245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
11 Ahnaou A, Drinkenburg W. Neuropeptide-S Evoked Arousal with Electroencephalogram Slow-Wave Compensatory Drive in Rats. Neuropsychobiology 2012;65:195-205. [DOI: 10.1159/000336998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cai Z, Liu H, Wang L, Li X, Bai L, Gan X, Li L, Han C. Molecular Evolutionary Analysis of the HCRTR Gene Family in Vertebrates. Biomed Res Int 2018;2018:8120263. [PMID: 29967787 DOI: 10.1155/2018/8120263] [Reference Citation Analysis]
13 Shukla C, Basheer R. Metabolic signals in sleep regulation: recent insights. Nat Sci Sleep 2016;8:9-20. [PMID: 26793010 DOI: 10.2147/NSS.S62365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
14 Molari A, Carcassi C. HLA and narcolepsy-cataplexy in the Sardinian population: Letter to the Editor. Journal of Sleep Research 2010;19:624-5. [DOI: 10.1111/j.1365-2869.2010.00849.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
15 Kram DE, Krasnow SM, Levasseur PR, Zhu X, Stork LC, Marks DL. Dexamethasone Chemotherapy Does Not Disrupt Orexin Signaling. PLoS One 2016;11:e0168731. [PMID: 27997622 DOI: 10.1371/journal.pone.0168731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Luca G, Haba-rubio J, Dauvilliers Y, Lammers G, Overeem S, Donjacour CE, Mayer G, Javidi S, Iranzo A, Santamaria J, Peraita-adrados R, Hor H, Kutalik Z, Plazzi G, Poli F, Pizza F, Arnulf I, Lecendreux M, Bassetti C, Mathis J, Heinzer R, Jennum P, Knudsen S, Geisler P, Wierzbicka A, Feketeova E, Pfister C, Khatami R, Baumann C, Tafti M; European Narcolepsy Network (EU-NN). Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res 2013;22:482-95. [DOI: 10.1111/jsr.12044] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 13.9] [Reference Citation Analysis]
17 Lee MJ, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Sun CC, Shyu YC, Wang LJ. Comorbidity of narcolepsy and depressive disorders: a nationwide population-based study in Taiwan. Sleep Med 2017;39:95-100. [PMID: 29157595 DOI: 10.1016/j.sleep.2017.07.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
18 Plazzi G, Moghadam KK, Maggi LS, Donadio V, Vetrugno R, Liguori R, Zoccoli G, Poli F, Pizza F, Pagotto U, Ferri R. Autonomic disturbances in narcolepsy. Sleep Medicine Reviews 2011;15:187-96. [DOI: 10.1016/j.smrv.2010.05.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
19 Katzav A, Arango MT, Kivity S, Tanaka S, Givaty G, Agmon-levin N, Honda M, Anaya J, Chapman J, Shoenfeld Y. Passive transfer of narcolepsy: Anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. Journal of Autoimmunity 2013;45:24-30. [DOI: 10.1016/j.jaut.2013.06.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
20 Tabikh M, Chahla C, Okdeh N, Kovacic H, Sabatier J, Fajloun Z. Parkinson disease: protective role and function of neuropeptides. Peptides 2021. [DOI: 10.1016/j.peptides.2021.170713] [Reference Citation Analysis]
21 Fronczek R, van Geest S, Frölich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF. Hypocretin (orexin) loss in Alzheimer’s disease. Neurobiol Aging. 2012;33:1642-1650. [PMID: 21546124 DOI: 10.1016/j.neurobiolaging.2011.03.014] [Cited by in Crossref: 130] [Cited by in F6Publishing: 120] [Article Influence: 11.8] [Reference Citation Analysis]
22 Mignot E. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2011. pp. 938-56. [DOI: 10.1016/b978-1-4160-6645-3.00084-0] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
23 Teske JA, Billington CJ, Kotz CM. Hypocretin/orexin and energy expenditure. Acta Physiol (Oxf) 2010;198:303-12. [PMID: 20070282 DOI: 10.1111/j.1748-1716.2010.02075.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
24 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
25 Oliveira LM, Henrique E, Bustelli IB, Netto NF, Moreira TS, Takakura AC, Caetano AL. Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model. Experimental Neurology 2020;323:113110. [DOI: 10.1016/j.expneurol.2019.113110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Economou N, Manconi M, Ghika J, Raimondi M, Bassetti CL. Development of Parkinson and Alzheimer Diseases in Two Cases of Narcolepsy-Cataplexy. Eur Neurol 2012;67:48-50. [DOI: 10.1159/000334733] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
27 Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauß M, Baum P, Hegerl U, Schönknecht P. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Research 2011;190:240-3. [DOI: 10.1016/j.psychres.2011.06.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
28 Mavanji V, Butterick TA, Duffy CM, Nixon JP, Billington CJ, Kotz CM. Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice. Neurobiol Learn Mem 2017;146:21-30. [PMID: 29107703 DOI: 10.1016/j.nlm.2017.10.014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
29 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Sanford LD, Tang X. Polysomnographic nighttime features of narcolepsy: A systematic review and meta-analysis. Sleep Med Rev 2021;58:101488. [PMID: 33934047 DOI: 10.1016/j.smrv.2021.101488] [Reference Citation Analysis]
30 Mignot E. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 855-872.e7. [DOI: 10.1016/b978-0-323-24288-2.00089-1] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Slats D, Claassen JA, Verbeek MM, Overeem S. Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: focus on the role of hypocretin and melatonin. Ageing Res Rev 2013;12:188-200. [PMID: 22575905 DOI: 10.1016/j.arr.2012.04.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
32 Yan A, Zhang L, Tang Z, Zhang Y, Qin C, Li B, Li W, Lin H. Orange-spotted grouper (Epinephelus coioides) orexin: Molecular cloning, tissue expression, ontogeny, daily rhythm and regulation of NPY gene expression. Peptides 2011;32:1363-70. [DOI: 10.1016/j.peptides.2011.05.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
33 Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013;31:1246-54. [PMID: 23246544 DOI: 10.1016/j.vaccine.2012.12.015] [Cited by in Crossref: 159] [Cited by in F6Publishing: 140] [Article Influence: 15.9] [Reference Citation Analysis]
34 Kalamatianos T, Markianos M, Margetis K, Bourlogiannis F, Stranjalis G. Higher Orexin A levels in lumbar compared to ventricular CSF: a study in idiopathic normal pressure hydrocephalus. Peptides 2014;51:1-3. [PMID: 24172541 DOI: 10.1016/j.peptides.2013.10.016] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
35 Erichsen JM, Calva CB, Reagan LP, Fadel JR. Intranasal insulin and orexins to treat age-related cognitive decline. Physiol Behav 2021;234:113370. [PMID: 33621561 DOI: 10.1016/j.physbeh.2021.113370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Thannickal TC. A decade of hypocretin/orexin: Accomplishments in sleep medicine. Sleep Medicine Reviews 2009;13:5-8. [DOI: 10.1016/j.smrv.2008.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
37 Chen TY, Huang CH, Chung CH, Mao WC, Yeh CB, Yang CCH, Kuo TBJ, Yang SS, Chien WC, Tzeng NS. Sex and age differences in the association between anxiety disorders and narcolepsy: A nationwide population-based case control study. J Affect Disord 2020;264:130-7. [PMID: 32056742 DOI: 10.1016/j.jad.2019.12.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
38 Cui LB, Li BW, Jin XH, Zhao L, Shi J. Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson's disease. Neurosci Bull 2010;26:381-7. [PMID: 20882064 DOI: 10.1007/s12264-010-0410-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]